Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.55 - $0.88 $4,099 - $6,559
-7,454 Reduced 33.62%
14,720 $10,000
Q3 2023

Nov 14, 2023

BUY
$0.69 - $1.53 $15,300 - $33,926
22,174 New
22,174 $15,000
Q1 2023

May 15, 2023

BUY
$1.54 - $2.68 $40,338 - $70,199
26,194 New
26,194 $50,000
Q3 2021

Nov 16, 2021

SELL
$2.98 - $3.48 $78,633 - $91,826
-26,387 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$3.01 - $3.78 $79,424 - $99,742
26,387 New
26,387 $87,000
Q4 2020

Feb 17, 2021

SELL
$2.88 - $4.33 $34,928 - $52,514
-12,128 Closed
0 $0
Q3 2020

Nov 17, 2020

SELL
$2.94 - $4.05 $110,732 - $152,539
-37,664 Reduced 75.64%
12,128 $38,000
Q2 2020

Aug 17, 2020

BUY
$2.89 - $4.32 $55,092 - $82,352
19,063 Added 62.04%
49,792 $194,000
Q1 2020

May 15, 2020

BUY
$2.47 - $5.16 $75,900 - $158,561
30,729 New
30,729 $96,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $35M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.